Correlation Between Navient and Centessa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Navient and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navient and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navient 675 percent and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Navient and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navient with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navient and Centessa Pharmaceuticals.

Diversification Opportunities for Navient and Centessa Pharmaceuticals

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Navient and Centessa is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Navient 675 percent and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Navient is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navient 675 percent are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Navient i.e., Navient and Centessa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Navient and Centessa Pharmaceuticals

Assuming the 90 days trading horizon Navient 675 percent is expected to under-perform the Centessa Pharmaceuticals. But the bond apears to be less risky and, when comparing its historical volatility, Navient 675 percent is 9.74 times less risky than Centessa Pharmaceuticals. The bond trades about -0.11 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1,579  in Centessa Pharmaceuticals PLC on September 19, 2024 and sell it today you would earn a total of  145.00  from holding Centessa Pharmaceuticals PLC or generate 9.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy92.86%
ValuesDaily Returns

Navient 675 percent  vs.  Centessa Pharmaceuticals PLC

 Performance 
       Timeline  
Navient 675 percent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Navient 675 percent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navient is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Centessa Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Navient and Centessa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Navient and Centessa Pharmaceuticals

The main advantage of trading using opposite Navient and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navient position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.
The idea behind Navient 675 percent and Centessa Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency